Pediatric AML exhibits higher frequency of structural abnormalities; only 20% of pediatric AML cases have a normal karyotype and less cooperative genetic alterations, such as mutations in genes FLT3, NPM1, and CEBPA, often found in adult AML. This evidence concerns the gene CEBPA and acute myeloid leukemia.